Role of hydrogen sulfide in asthma

doi:10.16352/j.issn.1001-6325.2025.09.1239

Abstract

Abstract: Asthma is one of the most common diseases in chronic respiratory system; the etiology is complex, involving many types of inflammatory cells and a variety of signaling molecular mediators. Hydrogen sulfide (H₂S) is an endogenous gas transmitter in mammals, which is widely involved in cell functions and physiological and pathological processes of various diseases, including respiratory diseases. H₂S is involved in the occurrence and development of asthma through various ways. When the H₂S-producing enzyme level decreases, the concentration of endogenous H₂S level may trigger asthma attack and play a pro-inflammatory role. On the other hand, H₂S initiates pulmonary inducible nitric oxide synthase (iNOS) activation, limiting airway remodeling, and acts as an anti-remodeling and anti-inflammatory mediator. Moreover, H₂S level varies at different stages of asthma. H₂S level in patients with asthma is a potential bio-markers of airway inflammation in asthma case and my support clinical diagnosis of asthma.

Key words: hydrogen sulfide, asthma, mechanism of action, biomarker

CLC Number:

R563
R446

CUI Xinyue, HAN Shasha. Role of hydrogen sulfide in asthma[J]. Basic & Clinical Medicine, 2025, 45(9): 1239-1242.

References 20

[1]	Chen YH, Wu R, Geng B, et al. Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma[J]. Cytokine, 2009, 45: 117-123.
[2]	Prado CM, Leick-Maldonado EA, Yano L, et al. Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling[J]. Am J Respir Cell Mol Biol,2006, 35: 457-465.
[3]	张伟才,刘肆仁,王尚农.硫氢化钠减轻高糖高脂诱导的大鼠心肌细胞系H9C2线粒体损伤[J].基础医学与临床,2023,43:1834-1840.
[4]	Bhatia M, Gaddam RR. Hydrogen sulfide in inflamma-tion: a novel mediator and therapeutic target[J]. Antioxid Redox Signal, 2021, 34: 1368-1377.
[5]	Katsouda A, Bibli S I, Pyriochou A, et al. Regulation and role of endogenously produced hydrogen sulfide in angiogene-sis[J]. Pharmacol Res, 2016, 113: 175-185.
[6]	Suzuki Y, Saito J, Munakata M, et al. Hydrogen sulfide as a novel biomarker of asthma and chronic obstructive pulmonary disease[J]. Allergol Int, 2021, 70: 181-189.
[7]	Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator[J]. J Neurosci, 1996, 16: 1066-1071.
[8]	Wu D, Wang J, Li H, et al. Role of hydrogen sulfide in ischemia-reperfusion injury[J]. Oxid Med Cell Longev, 2015, 2015: 186908.doi:10.1155/2015/186908.
[9]	Fitzgerald R, DeSantiago B, Lee DY, et al. H2S relaxes isolated human airway smooth muscle cells via the sarcolemmal KATP channel[J]. Biochem Biophys Res Commun, 2014, 446: 393-398.
[10]	Escamilla-Gil JM, Fernandez-Nieto M, Acevedo N. Understanding the cellular sources of the fractional exhaled nitric oxide (FeNO) and its role as a biomarker of type 2 inflammation in asthma[J]. Biomed Res Int, 2022, 2022: 5753524.doi:10.1155/2022/5753524.
[11]	Chen YH, Wu R, Geng B, et al. Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma[J]. Cytokine, 2009, 45: 117-123.
[12]	刘慧芳,姜敏,马红霞. 哮喘大鼠肺组织线粒体功能变化及其对氧化应激水平的影响[J]. 新乡医学院学报, 2018, 35: 662-665.
[13]	Khattak S, Zhang QQ, Sarfraz M, et al. The role of hydrogen sulfide in respiratory diseases[J]. Biomolecules, 2021, 11: 682.doi:10.3390/biom11050682.
[14]	Zhang HX, Liu SJ, Tang XL, et al. H2S attenuates LPS-induced acute lung injury by reducing oxidative/nitrative stress and inflammation[J]. Cell Physiol Biochem, 2016, 40: 1603-1612.
[15]	文勃,李玲,冯杨,等.哮喘患儿血清H2S,IgE,PTX3水平与疾病进展的关系探讨[J].国际检验医学杂志, 2023, 44:1210-1213.
[16]	Suzuki Y, Saito J, Kikuchi M, et al. Sputum-to-serum hydrogen sulphide ratio as a novel biomarker of predicting future risks of asthma exacerbation[J]. Clin Exp Allergy, 2018, 48: 1155-1163.
[17]	黄海英,何庆娟,孙宝兰,等.支气管哮喘患儿血浆H2S水平变化及意义[J].山东医药, 2017, 57:4.doi:CNKI:SUN:SDYY.0.2017-37-007.
[18]	Gao W, Han GJ, Zhu YJ, et al. Clinical character-istics and biomarkers analysis of asthma inflammatory pheno-types[J]. Biomark Med, 2020, 14: 211-222.
[19]	刘志群, 于贺, 王国茗. 探讨哮喘患者的气道炎症表型分布及临床特征[J]. 中国医药指南, 2019, 17.doi:10.15912/j.cnki.gocm.2019.27.114.
[20]	Zhang J, Wang X, Chen Y, et al. Correlation between levels of exhaled hydrogen sulfide and airway inflammatory phenotype in patients with chronic persistent asthma[J]. Respirology, 2014, 19: 1165-1169.